期刊文献+

梯度洗脱HPLC测定辛伐他汀片的含量和有关物质 被引量:10

Determination of Content and the Related Substances of Simvastatin Tablets by HPLC
原文传递
导出
摘要 目的建立辛伐他汀片含量测定及有关物质的检查方法。方法采用反相高效液相色谱法,色谱柱:SUPELCO C18柱(4.6mm×33mm,3μm),以乙腈-0.1%磷酸(50:50)为流动相A,0.1%磷酸乙腈溶液为流动相B,线性梯度洗脱,流速:3.0mL.min-1,检测波长238nm。结果辛伐他汀与洛伐他汀及强制破坏产生的降解产物均分离良好,辛伐他汀浓度在21.88~196.9μg.mL-1内,与峰面积呈良好的线性关系,回归方程A=65929ρ+4676,r=0.9996(n=7);日内精密度为0.54%(n=5);日间精密度为0.85%(n=5);平均回收率为99.55%(RSD=0.67%,n=9);样品溶液至少在3h内稳定;最低检测限为25.14ng.mL-1。结论该法专属性强,准确、灵敏,可用于辛伐他汀片的含量测定和有关物质检查。 OBJECTIVE To establish a method for determining the content and related substances of simvastatin tablets.METHODS The separation was carried out on a SUPELCO C18 column (3 μm,4.6 mm×33 mm) with gradient elution.The mobile phase consisted of acetonitrile-0.1% phosphoric acid solution (50:50) as the mobile phase A,and 0.1% phosphoric acid in acetonitrile as the mobile phase B.The flow rate was at 3.0 mL·min-1and the detection wavelength was at 238 nm.RESULTS The resolution between the peak of losvatatin and simvastatin was above 5.0.The linear range of the method was 21.88-196.9 μg·mL^-1nd the regression equation was A=65 929ρ+4 676 (r=0.999 6,n=7).The average recovery was 99.55%(RSD=0.67%,n=9) and the limit of detection was 25.14 ng·mL^-1.The sample solution was stable within 3 h.CONCLUSION The method is specific,accurate,sensitive and can be used for the determination of content and related substances of simvastatin tablets.
出处 《中国药学杂志》 CAS CSCD 北大核心 2010年第9期702-705,共4页 Chinese Pharmaceutical Journal
关键词 辛伐他汀片 含量测定 有关物质 高效液相色谱法 simvastatin tablets assay related substances HPLC
  • 相关文献

参考文献7

  • 1PLOSKER G L, METAV1SH D. Simvastatin: a reappraisal of its pharmacology and therapeutic efficacy in hypercholesterolaemia [J]. Drugs, 1995, 50(2) :334-363.
  • 2高智耀,雷兆军,李亚军,王晓明.辛伐他汀在不稳定型心绞痛患者早期应用的疗效[J].心脏杂志,2004,16(2):140-142. 被引量:19
  • 3HEBERT P R, GAZIANG J M, CHARLES K C, et al. Cholesterol lowering with statin drugs, Risk of stroke, and total mortality [J]. JAMA ,1997,278(4) :313-321.
  • 4State drug standard(国家药品标准)WS1-(X-240)-2004Z[S].2004,57:53-55.
  • 5USP(32) [S]. 2009:3556-3557.
  • 6ZHOUH LINL.Determination of related substances of Simvastatin tablets.中国药业,2009,18(4):37-38.
  • 7杨晓白,张茹英,张玉珍.辛伐他汀片中有关物质的HPLC测定[J].浙江化工,2005,36(6):34-35. 被引量:5

二级参考文献29

  • 1郭继鸿.新概念心电图[M].北京:北京医科大学出版社,2002.433-434.
  • 2Sacks FM. Lipid-lowering therapy in acute coronary syndromes[J]. JAMA, 2001, 285,1758-1760.
  • 3Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Evaluation Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol (Adults Treatment Panel Ⅲ )[J]. JAMA,2001, 285:2486-2497.
  • 4The Long-Term Intervention with Pravastatin in Ischemic Disense (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad rang of initial cholesterol level[J]. N Engl J Med, 1998, 339:1349-1357.
  • 5Mueck AO, Seeger H. Further evidence for direct vascular actions of statins: effect on endothelial nitric oxide synthase and adhesion molecules [J].Eacp Clin Endocrinol Diabetes, 2001,I09:181-183.
  • 6Musisal J, Undas A, Gajewski P, et al. anti-inflammatory effects of Simvastatin in subjects with hypercholesterolemia[J]. Int J Cardiol, 2001, 7:247-1253.
  • 7Wong B, Lumma WC, Smith AM, et al. Statins suppress TGP-1 cell migration and secretion of matrix metalloproteinase 9 by inhibiting geranyl-geranglation [J].J Leukoc Biol, 2001.69,959- 962.
  • 8Capurse A. Le Promesse delle statine. [The promise of statins] [J].Ital Heart J,2001, 2:224 -229.
  • 9Chirkov YY, Holmes AS, Willoughby SR, et al. Stable angina and acute coronary syndromes are associate with nitric oxide resistance in platelets [J]. J Am Coll Cardiol, 2001, 37:1851-1857.
  • 10Undas A, Brummel KE, Musial J, et al. Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor Ⅴ and ⅩⅢ and by enhanceing factor V a inactivation [J]. Circulation,2001,103 : 2248- 2253.

共引文献22

同被引文献88

引证文献10

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部